[Federal Register: April 4, 2005 (Volume 70, Number 63)]
[Notices]
[Page 17124]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ap05-133]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on February 7, 2005, Johnson
Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive,
West Deptford, New Jersey 08066, made application by letter to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of Methamphetamine (1105), a basic class of controlled
substance listed in Schedule II.
    The company plans to manufacture the listed controlled substance in
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than June 3, 2005.

    Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6586 Filed 4-1-05; 8:45 am]

BILLING CODE 4410-09-P